scholarly journals Endoscopic submucosal dissection of a huge esophageal atypical lipomatous tumor (well-differentiated liposarcoma) with a 4-year recurrence-free survival

Endoscopy ◽  
2017 ◽  
Vol 49 (10) ◽  
pp. E237-E239
Author(s):  
Ming-Yan Cai ◽  
Jia-Xin Xu ◽  
Ping-Hong Zhou
Endoscopy ◽  
2020 ◽  
Vol 52 (12) ◽  
pp. 1066-1074 ◽  
Author(s):  
Yuhang Zhang ◽  
Ling Liu ◽  
Qiming Wang ◽  
Linjie Guo ◽  
Liansong Ye ◽  
...  

Background Endoscopic submucosal dissection (ESD) is effective for treating T1a early esophageal squamous cell carcinoma (ESCC). However, occasional recurrences are inevitable. This trial was designed to clarify the efficacy of combining ESD with additional radiotherapy in the treatment of T1a ESCC. Methods Between January 2015 and September 2018, patients with early ESCC (T1aN0M0) following ESD were randomly assigned (1:1) to the radiotherapy group or non-radiotherapy group. Patients in the radiotherapy group received a median radiation dose of 59.4 Gy within 2 months after ESD. In the non-radiotherapy group, patients underwent regular follow-up only. Recurrence-free survival, cancer-specific survival, overall survival, and complications were evaluated. Results 70 patients completed the per-protocol treatment. Three patients in the non-radiotherapy group experienced intraluminal mucosal recurrence compared with none in the radiotherapy group. No local lymph node or distant metastases occurred in either group. The 3-year cumulative recurrence-free survival was 100 % in the radiotherapy group and 85.3 % in the non-radiotherapy group (P = 0.04; hazard ratio 0.08, 95 % confidence interval [CI] 0.01 – 0.86). However, there was no significant difference in RFS between the treatments within the T1a invasion subgroups (P > 0.05). No patient died in either group. Mucosal defects of more than three-quarters of the esophageal circumference were positively correlated with stenosis (P < 0.01; odds ratio 23.26, 95 %CI 4.04 – 133.86). No severe radiation toxicities were recorded. Conclusions Radiotherapy after ESD might be a safe and effective optional therapeutic strategy to prevent recurrence of T1a ESCC.


2019 ◽  
Vol 35 (3) ◽  
pp. e76-e80 ◽  
Author(s):  
Kyle McKey ◽  
Paul J. L. Zhang ◽  
Carol L. Shields ◽  
Sara E. Lally ◽  
Ralph C. Eagle ◽  
...  

2020 ◽  
Vol 7 ◽  
Author(s):  
Emi Mashima ◽  
Yu Sawada ◽  
Natsuko Saito-Sasaki ◽  
Kayo Yamamoto ◽  
Shun Ohmori ◽  
...  

Atypical lipomatous tumor (ALT) has been defined as a well-differentiated liposarcoma exhibiting a higher frequency of a local recurrence after surgical resection. ALT is mainly classified into deep type and superficial type. Compared with deep type ALT, superficial type ALT is rarely observed. One of the most important issues is that little has been known about superficial type ALT and it is not easy to predict the presence of superficial type ALT before surgical resection. To clarify the clinical manifestations of superficial type ALT, we examined 15 cases with superficial type ALT and 118 cases with benign lipoma, and analyzed their differences in clinical characteristics and the findings of MRI test. In clinical characteristics, the tumor size of superficial type ALT was significantly greater than that of benign lipoma, and superficial type ALT showed a significantly higher frequency of the tumor size of more than 4 cm. Superficial type ALT exhibited poor tumor mobility and hardness with elastic soft. In addition, a significantly higher frequency of tumor location of superficial type ALT was observed in extremities. Among tumor sites at the trunk, buttocks, and shoulder were high frequent location in superficial type ALT. In an MRI examination, superficial type ALT exhibited a significantly higher frequency of the septal structures compared with benign lipoma. The combinations of clinical characteristics, including physical examinations, MRI, and histological examinations, are helpful for the diagnosis of superficial type ALT.


2011 ◽  
Vol 4 (1) ◽  
pp. 178-185 ◽  
Author(s):  
Takashi Yuri ◽  
Takeshi Miyaso ◽  
Hiroaki Kitade ◽  
Kosho Takasu ◽  
Nobuaki Shikata ◽  
...  

2021 ◽  
Vol 67 (5) ◽  
pp. 265-269
Author(s):  
Eri FUKAYA ◽  
Fumihiko MATSUSHITA ◽  
Yoshiko WATANABE ◽  
Yoshiyuki UCHIYAMA ◽  
Kazuma MASUMOTO ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document